Neos Therapeutics Company Profile (NASDAQ:NEOS)

About Neos Therapeutics

Neos Therapeutics logoNeos Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. It has utilized its platform to develop its product for the treatment of attention deficit hyperactivity disorder (ADHD). Its product candidates are extended-release (XR), medications in patient-friendly, orally disintegrating tablets (ODT) or liquid suspension dosage forms. Its branded product and product candidates incorporate over two of the prescribed medications for the treatment of ADHD, methylphenidate and amphetamine. Its modified-release drug delivery platform has enabled it to create extended-release ODT and liquid suspension dosage forms of the medications. It focuses on developing Adzenys XR-ODT, Cotempla XR-ODT and NT-0201.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NEOS
  • CUSIP:
Key Metrics:
  • Previous Close: $7.14
  • 50 Day Moving Average: $7.39
  • 200 Day Moving Average: $9.01
  • 52-Week Range: $6.33 - $22.02
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.10
  • P/E Growth: -0.01
  • Market Cap: $111.20M
  • Outstanding Shares: 16,070,000
  • Beta: -1.4
Profitability:
  • Net Margins: -968.81%
  • Return on Equity: -80.10%
  • Return on Assets: -44.62%
Debt:
  • Debt-to-Equity Ratio: 1.44%
  • Current Ratio: 5.46%
  • Quick Ratio: 5.20%
Additional Links:
Companies Related to Neos Therapeutics:

Analyst Ratings

Consensus Ratings for Neos Therapeutics (NASDAQ:NEOS) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.33 (276.42% upside)

Analysts' Ratings History for Neos Therapeutics (NASDAQ:NEOS)
Show:
DateFirmActionRatingPrice TargetDetails
9/20/2016BMO Capital MarketsReiterated RatingBuy$15.00View Rating Details
5/18/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
5/17/2016Royal Bank Of CanadaLower Price TargetOutperform$33.00 -> $29.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$33.00 -> $32.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Neos Therapeutics (NASDAQ:NEOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/11/2016Q2($1.16)($1.65)$1.48 million$1.49 millionViewListenView Earnings Details
5/16/2016Q1($0.87)($0.79)ViewListenView Earnings Details
3/17/2016Q4($0.66)($0.57)$1.70 millionViewListenView Earnings Details
9/3/2015Q215($4.31)($7.76)$1.70 million$1.48 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neos Therapeutics (NASDAQ:NEOS)
Current Year EPS Consensus Estimate: $-5.39 EPS
Next Year EPS Consensus Estimate: $-3.21 EPS

Dividends

Dividend History for Neos Therapeutics (NASDAQ:NEOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neos Therapeutics (NASDAQ:NEOS)
Insider Ownership Percentage: 4.85%
Institutional Ownership Percentage: 37.73%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/31/2016Bryant FongDirectorBuy1,500$6.54$9,810.00View SEC Filing  
8/25/2016Richard I EisenstadtCFOBuy3,710$6.82$25,302.20View SEC Filing  
6/13/2016Juergen MartensInsiderBuy10,000$9.90$99,000.00View SEC Filing  
5/19/2016Alan L HellerDirectorBuy10,000$7.61$76,100.00View SEC Filing  
5/19/2016Thomas P McdonnellInsiderBuy3,000$7.56$22,680.00View SEC Filing  
5/18/2016Gregory J RobitailleDirectorBuy7,442$7.55$56,187.10View SEC Filing  
4/20/2016Presidio Partners 2007, L.P.Major ShareholderSell20,367$9.98$203,262.66View SEC Filing  
4/15/2016Presidio Partners 2007, L.P.Major ShareholderSell57,968$10.23$593,012.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Neos Therapeutics (NASDAQ:NEOS)
DateHeadline
businesswire.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Neos Therapeutics, Inc ... - Business Wire (press release) (NASDAQ:NEOS)
www.businesswire.com - September 22 at 11:09 AM
prnewswire.com logoNEOS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launch Investigation of Neos Therapeutics, Inc. for ... - PR Newswire (press release) (NASDAQ:NEOS)
www.prnewswire.com - September 22 at 11:09 AM
prnewswire.com logoNEOS THERAPEUTICS NOTIFICATION: Faruqi & Faruqi, LLP ... - PR Newswire (press release) (NASDAQ:NEOS)
www.prnewswire.com - September 22 at 11:09 AM
finance.yahoo.com logoNEOS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launch Investigation of Neos Therapeutics, Inc. for Possible Securities Fraud Violations (NASDAQ:NEOS)
finance.yahoo.com - September 21 at 6:01 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Neos Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:NEOS)
finance.yahoo.com - September 21 at 6:01 PM
finance.yahoo.com logoNEOS THERAPEUTICS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess … (NASDAQ:NEOS)
finance.yahoo.com - September 21 at 10:29 AM
finance.yahoo.com logoNEOS THERAPEUTICS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Neos Therapeutics, Inc. To Contact The Firm (NASDAQ:NEOS)
finance.yahoo.com - September 21 at 10:29 AM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Neos Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:NEOS)
finance.yahoo.com - September 21 at 10:29 AM
4-traders.com logoKhang & Khang LLP Announces an Investigation of Neos Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:NEOS)
www.4-traders.com - September 20 at 11:37 AM
News IconIMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Neos Therapeutics, Inc. & Advises Investors with Losses... (NASDAQ:NEOS)
ih.advfn.com - September 20 at 11:37 AM
News IconInvestor News: Neos Therapeutics Inc (NASDAQ:NEOS) under Investigation over potential Wrongdoing (NASDAQ:NEOS)
www.groundreport.com - September 20 at 11:37 AM
News IconIMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Neos Therapeutics, Inc. and Advises ... - Yahoo Sports (NASDAQ:NEOS)
sports.yahoo.com - September 19 at 6:22 PM
businesswire.com logoINVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Neos Therapeutics, Inc. and Encourages ... - Business Wire (press release) (NASDAQ:NEOS)
www.businesswire.com - September 19 at 6:22 PM
prnewswire.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Neos Therapeutics, Inc ... - PR Newswire (press release) (NASDAQ:NEOS)
www.prnewswire.com - September 19 at 6:22 PM
prnewswire.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neos Therapeutics, Inc ... - PR Newswire (press release) (NASDAQ:NEOS)
www.prnewswire.com - September 19 at 6:22 PM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Neos Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:NEOS)
finance.yahoo.com - September 19 at 6:22 PM
finance.yahoo.com logoNEOS SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Neos Therapeutics, Inc. and Certain Officers and Directors-- NEOS (NASDAQ:NEOS)
finance.yahoo.com - September 19 at 6:22 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Neos Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:NEOS)
finance.yahoo.com - September 19 at 6:22 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Neos Therapeutics, Inc. (NEOS) (NASDAQ:NEOS)
finance.yahoo.com - September 19 at 10:52 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neos Therapeutics, Inc. - NEOS (NASDAQ:NEOS)
finance.yahoo.com - September 19 at 10:52 AM
businesswire.com logoNEOS INVESTOR ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving ... - Business Wire (press release) (NASDAQ:NEOS)
www.businesswire.com - September 16 at 6:05 PM
businesswire.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Claims against Neos Therapeutics, Inc. and ... - Business Wire (press release) (NASDAQ:NEOS)
www.businesswire.com - September 16 at 6:05 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Claims against Neos Therapeutics, Inc. … (NASDAQ:NEOS)
finance.yahoo.com - September 16 at 9:53 AM
4-traders.com logoGoldberg Law PC Announces an Investigation of Claims against Neos Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:NEOS)
www.4-traders.com - September 16 at 9:53 AM
News IconSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Claims against Neos Therapeutics, Inc. & Advises Investors w... (NASDAQ:NEOS)
ih.advfn.com - September 16 at 9:53 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Claims against Neos Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:NEOS)
finance.yahoo.com - September 16 at 9:53 AM
4-traders.com logoFitch Rates $4.7MM Champaign, IL GO Bonds 'AAA'; Outlook Stable (NASDAQ:NEOS)
www.4-traders.com - September 15 at 6:25 PM
reuters.com logoFOREX-Dollar eases on uncertainty over BOJ, Fed policy (NASDAQ:NEOS)
in.reuters.com - September 15 at 6:25 PM
News IconNEOS INVESTOR ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud... (NASDAQ:NEOS)
ih.advfn.com - September 15 at 6:25 PM
businesswire.com logoNEOS INVESTOR ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Neos Therapeutics, Inc. and Certain ... (NASDAQ:NEOS)
www.businesswire.com - September 15 at 6:25 PM
finance.yahoo.com logoNEOS INVESTOR ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Neos Therapeutics, Inc. and Certain Officers and Directors (NASDAQ:NEOS)
finance.yahoo.com - September 15 at 6:25 PM
News IconNeos Therapeutics Inc. (NEOS) Shares Down 4.7% - NewsDen (NASDAQ:NEOS)
newsden.net - September 15 at 9:49 AM
reuters.com logoBRIEF-John Patience reports 5.1 pct passive stake in Neos Therapeutics - Reuters (NASDAQ:NEOS)
www.reuters.com - September 15 at 9:49 AM
News IconWhat's Next for Neos Therapeutics Inc After Today's Huge Increase ... - Chester News (NASDAQ:NEOS)
www.chesterindependent.com - September 15 at 9:49 AM
News IconNeos Therapeutics Inc (NASDAQ:NEOS) Under Investor Investigation over Potential Wrongdoing - Digital Journal (NASDAQ:NEOS)
www.digitaljournal.com - September 13 at 11:11 AM
newsmaker.com.au logoGlobal Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2016 Forecasts to 2021 (NASDAQ:NEOS)
www.newsmaker.com.au - September 12 at 6:03 PM
News IconStock Showing Gains in Afternoon Trading: Neos Therapeutics, Inc. (NASDAQ:NEOS) - National Daily Press (NASDAQ:NEOS)
www.nationaldailypress.com - September 10 at 5:45 PM
News IconShares Higher in Today's Session: Neos Therapeutics, Inc. (NASDAQ:NEOS) - Post News (NASDAQ:NEOS)
www.kentuckypostnews.com - September 8 at 6:08 PM
News IconWall Street Analysts Watch-list: VBI Vaccines Inc. (NASDAQ:VBIV) , Neos Therapeutics, Inc. (NASDAQ:NEOS) - Wall Street Times (press release) (NASDAQ:NEOS)
www.wallstreetnews24.com - September 3 at 10:43 AM
finance.yahoo.com logoNEOS SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving … (NASDAQ:NEOS)
finance.yahoo.com - September 1 at 6:18 PM
finance.yahoo.com logoNEOS SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Neos Therapeutics, Inc. and Certain Officers and Directors-- NEOS (NASDAQ:NEOS)
finance.yahoo.com - September 1 at 6:18 PM
streetinsider.com logoForm 4 Neos Therapeutics, Inc. For: Aug 31 Filed by: Fong Bryant - StreetInsider.com (NASDAQ:NEOS)
www.streetinsider.com - September 1 at 9:33 AM
finance.yahoo.com logoNeos Therapeutics to Present at the Wells Fargo Securities Healthcare Conference on September 8, 201 … (NASDAQ:NEOS)
finance.yahoo.com - August 31 at 11:23 AM
finance.yahoo.com logoNeos Therapeutics to Present at the Wells Fargo Securities Healthcare Conference on September 8, 2016 (NASDAQ:NEOS)
finance.yahoo.com - August 31 at 11:23 AM
finance.yahoo.com logoNEOS THERAPEUTICS, INC. Financials (NASDAQ:NEOS)
finance.yahoo.com - August 26 at 6:07 PM
live-pr.com logo"Neos Therapeutics, Inc. (NEOS) - Financial and Strategic SWOT Analysis Review" now available at Fast Market Research (NASDAQ:NEOS)
www.live-pr.com - August 26 at 9:26 AM
finance.yahoo.com logoEdited Transcript of NEOS earnings conference call or presentation 11-Aug-16 12:30pm GMT (NASDAQ:NEOS)
finance.yahoo.com - August 19 at 6:21 PM
capitalcube.com logoETF’s with exposure to Neos Therapeutics, Inc. : August 15, 2016 (NASDAQ:NEOS)
www.capitalcube.com - August 15 at 6:41 PM
capitalcube.com logoNeos Therapeutics, Inc. :NEOS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:NEOS)
www.capitalcube.com - August 12 at 6:32 PM
News IconNeos Therapeutics Announces Second Quarter 2016 Financial Results - P&T Community (NASDAQ:NEOS)
www.ptcommunity.com - August 12 at 9:39 AM

Social

Neos Therapeutics (NASDAQ:NEOS) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff